Health Care & Life Sciences » Pharmaceuticals » Novartis | Novartis R&D expenditure 2004-2017

Novartis' expenditure on research and development 2004-2017

Novartis AG's expenditure on research and development from 2004 to 2017 (Figures expressed in billions of U.S. dollars, unless otherwise specified)

The data displays the expenditure on research and development of Swiss-based pharmaceutical company Novartis from 2004 to 2017. Novartis AG is one of the world's biggest pharma companies. In 2004, Novartis spent approx. four billion USD on research and development.

2004	4
2005	4.8
2006	5.3
2007	6.2
2008	7.2
2009	7.3
2010	8.1
2011	8.4
2012	8.4
2013	8.9
2014	8.7
2015	8.7
2016	8.4
2017	8.3

Novartis' expenditure on research and development 2004-2017

StatInvestor